NYSE - Nasdaq Real Time Price USD

Integer Holdings Corporation (ITGR)

121.21 +20.35 (+20.18%)
At close: 31 July at 4:00:03 pm GMT-4
121.44 +0.23 (+0.19%)
After hours: 31 July at 7:57:48 pm GMT-4
Chart Range Bar
Loading chart for ITGR
  • Previous close 100.86
  • Open 100.87
  • Bid 121.36 x 80000
  • Ask 122.18 x 10000
  • Day's range 99.52 - 123.50
  • 52-week range 62.00 - 123.50
  • Volume 2,355,408
  • Avg. Volume 531,492
  • Market cap (intra-day) 4.116B
  • Beta (5Y monthly) 0.64
  • PE ratio (TTM) 24.99
  • EPS (TTM) 4.85
  • Earnings date 6 Aug 2026
  • Forward dividend & yield --
  • Ex-dividend date --
  • 1y target est 101.20

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

www.integer.net

11,000

Full-time employees

31 December

Fiscal year ends

Healthcare

Sector

Medical Devices

Industry

Performance overview

Trailing total returns as of 31/07/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD return

ITGR
54.55%
S&P 500 (^GSPC)
9.41%

1-year return

ITGR
11.70%
S&P 500 (^GSPC)
18.15%

3-year return

ITGR
31.07%
S&P 500 (^GSPC)
63.21%

5-year return

ITGR
23.82%
S&P 500 (^GSPC)
70.40%

Earnings trends

View more

Earnings per share

GAAP
Normalised
GAAP
Normalised
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 439.58M
Earnings 16.51M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
100M
200M
300M
400M
 

Analyst insights

View more

Analysts' price targets

84.00 Low
101.20 Average
121.21 Current
115.00
 

Analyst recommendations

  • Strong buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest rating

Date 22/07/2026
Analyst Freedom Capital Markets
Rating action Initiated
Rating Buy
Price action Announces
Price target 112
 

Statistics

View more

Valuation measures

As of 30/07/2026
  • Market cap

    3.42B

  • Enterprise value

    4.80B

  • Trailing P/E

    25.03

  • Forward P/E

    21.60

  • PEG ratio (5-yr expected)

    2.70

  • Price/sales (ttm)

    1.94

  • Price/book (mrq)

    2.02

  • Enterprise value/revenue

    2.59

  • Enterprise value/EBITDA

    14.71

Financial highlights

Profitability and income statement

  • Profit margin

    7.64%

  • Return on assets (ttm)

    4.23%

  • Return on equity (ttm)

    8.59%

  • Revenue (ttm)

    1.86B

  • Net income avi to common (ttm)

    141.8M

  • Diluted EPS (ttm)

    4.85

Balance sheet and cash flow

  • Total cash (mrq)

    8.12M

  • Total debt/equity (mrq)

    81.41%

  • Levered free cash flow (ttm)

    98.14M

Compare

Select to analyse similar companies using key performance metrics; select up to four stocks.

People also watch